Response to: 'Potential roles for tenascin in (very) early diagnosis and treatment of rheumatoid arthritis' by Cutolo et al.

Aungier S., Cartwright AJ., Schwenzer A., Marshall J., Dyson MR., Slavny P., Parthiban K., Karatt-Vellatt A., Sahbudin I., Culbert E., Hextall P., Clanchy FI., Williams R., Marsden BD., Raza K., Filer A., Buckley CD., McCafferty J., Midwood KS.

DOI

10.1136/annrheumdis-2019-215108

Type

Journal article

Journal

Annals of the rheumatic diseases

Publication Date

04/2020

Volume

79

Addresses

Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.

Keywords

Humans, Arthritis, Rheumatoid, Tenascin, Antirheumatic Agents, Early Diagnosis, Immunomodulation

Permalink Original publication